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Abstract
Antisperm antibodies (ASA) may be a reason of infertility in some individuals. They may affect pre-
as well as post-fertilization stages of the reproductive process. There is ongoing progress in the
identification of sperm antigens related to fertilization. The employed methods for this purpose
include recombinant DNA technology and the most advanced proteomic analysis. This paper
enlists the different approaches undertaken in order to identify and characterize the
immunoreactive sperm antigens. We have mainly focused on those, which have been already
studied in regard of their immunocontraceptive potential, although it has been impossible to
include all published data concerning the topic in a single article. Few novel sperm auto- and
isoantigens, discovered recently, have also been reviewed even if their role in fertilization has not
been yet established.
Introduction
Infertility occurs in one out of the five couples of the
reproductive age. Some of these individuals (males and
females) possess antisperm antibodies in blood and
reproductive tract secretions. ASA may influence pre-ferti-
lization stages of the reproduction process (sperm aggluti-
nation and/or immobilization, sperm-oocyte
interactions) and they can inhibit the development of the
post-fertilization zygotes.
Identification and characterization of antigens present on
sperm cells is crucial for understanding their cognate ASA
relationship with infertility. However, due to the com-
plexity of polyclonal sera, containing ASA interacting in
most of the cases with multiple sperm components (either
specifically or by molecular mimicry), the identification
of a single immunodominant sperm antigen seems to be
impossible.
Interaction between antibodies and some of the sperm
membrane antigenic moieties may be regarded as a main
reason of immune infertility, because in live sperm cells
ASA are not able to penetrate through the plasmalemma
(except from the acrosomal antigens that appear on the
sperm surface after the acrosomal reaction). On the other
hand, detailed knowledge of the nature of sperm antigens,
engaged in immune reactions may be helpful in develop-
ing technology for contraceptive vaccination, based on
sperm – specific components, for regulation of fertility in
humans as well as in domestic and wild animals popula-
tions [1,2].
The administration of sperm antigenic cocktails, prepared
from whole semen specimens for immunocontraceptive
purposes is unacceptable due to the reported hypersensi-
tivity reactions against seminal plasma components [3]
and molecular mimicry with various somatic cells [4].
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ASA, despite the presence within the organism for years
do not exert any harmful effect on patients, except for
their infertility. One must remember, however, that not
all antisperm antibodies will alter sperm function, either
because the cognate antigen is not involved in the process
of fertilization or because the antibodies do not bind to
the functional domain of the antigen. It is well known
from monoclonal antibodies that the antibody-binding
region of the antigen may be different from the region
being active in metabolic processes [5].
In summary, the selection of a certain sperm antigen(s)
for the development of a contraceptive vaccine is limited
by its specificity, participation in the fertilization process
and its potential to induce a high sperm-specific antibody
titer in the genital tract.
Antibody identification of sperm antigens
Many methods can be used to identify of cognate antigens
of ASA. Therefore, antibodies secreted into body fluids of
spontaneously  in vivo sperm-sensitized males and
females, were employed for Western immunoblotting and
immunoprecipitation studies with sperm antigenic
extracts [6-11]. The produced data, indicating the molecu-
lar weight of relevant sperm antigens were, however, con-
flicting, probably due to differences either concerning a
methodology or selection of the studied populations of
the ASA-positive individuals. Besides, the molecular
weights of immunodominant entities were insufficient for
their subsequent characterization, including their primary
structure, tissue specificity and determination of the
immunogenic regions for subsequent cloning.
In addition, the use of circulating ASA may not be the
most appropriate way to identify the antigens really
involved in fertility, as the major antigens defined by cir-
culating ASA differ from the antigens recognized by
sperm-bound antibodies [12]. Thus, antibodies reacting
with the surface of human spermatozoa were isolated and
an enhanced chemiluminescence immunoblotting tech-
nique was used for analysis of sperm antigens recognized
by antibodies eluted from the surface of spermatozoa
obtained from infertile men with unsuccessful in vitro fer-
tilization [13]. In this study, 2 protein zones: 37/36 kDa
and 19/18 kDa were electroeluted from the preparative
slab gels and were used for biochemical characterization
and the production of polyclonal antibodies in rabbits.
Previously, [12] these proteins were recognized by anti-
bodies of the great majority of infertile individuals. Isoe-
lectric focusing showed that these peptides (designated as
P36 and P18) consisted of several polypeptides of the pI
4.5–8.3 for P36 and 4.75 to 5.9 and 7.0 – 10.3 for P18.
Human ASA reacted with few spots with pI 5.0 – 6.0 for
P36 and several spots with pI 8.3 – 10.3 for P18. Immun-
ofluorescent studies revealed the presence of these pep-
tides on sperm heads. Anti P36 antibodies reduced the
binding and penetration of zona-free hamster oocytes by
human sperm. Anti P18 antibodies reduced sperm-oocyte
penetration but did not significantly affect sperm binding.
In most of the published Western immunoblotting stud-
ies the reactions of sperm antigens with sera of fertile
patients were not analyzed. Hence, it was impossible to
reveal the role of these antigens in the fertilization proc-
ess.
Monoclonal antibodies may be also applied for identifica-
tion, isolation and characterization of sperm antigens.
Although many antigens have been identified by means of
monoclonal antibodies [14-19], the identification of
human homologues of antigens originally identified in an
animal model is often difficult as well as the purification
of sufficient natural product from human tissues for
detailed biochemical characterization and studying the
fertilization process in primates [20]. A solution could be
a combination of monoclonal antibodies (or ASA derived
from sera of infertile individuals as well as sperm-sensi-
tized animals) with testis cDNA libraries for direct identi-
fication of sperm-specific antigens. The advantage of this
approach is the direct confirmation of tissue-specificity of
relevant cDNA fragments. Since recombinant proteins are
lacking the carbohydrate moieties, their further analysis in
much simpler. Even if this approach is limited by the fact
that during maturation the sperm plasma membrane
undergoes changes (resulting in the appearance of new
antigenic components acquired in the epididymis [21]), it
has been successfully applied for identification of some
novel sperm antigens.
cDNA library screening
Sera of ASA-positive infertile patients allowed identifica-
tion of a novel 56 kDa antigen X-1 (AgX-1) from the
human λgt11 cDNA library [22].
In another study, the FA-1 [23] MoAb was used for a
screening of murine testis lambda gt11 cDNA expression
library [24]. The phage DNA of a positive clone was sub-
cloned and subsequently sequenced. Search in databases
did not identify any known nucleotide/amino acid (nt/
aa) sequences having homology with FA-1 cDNA or its
deduced aa sequence, suggesting a novel protein. The
recombinant FA-1 (rFA-1) was obtained and investigated
for its immunocontraceptive potential in mice [25]. The
immunization of female mice with the murine rFA-1 anti-
gen resulted in significant reduction of fertility that was
reversible when the antibody titer declined to the normal
level. Murine anti-rFA-1 antibodies blocked murine bind-
ing to ZP and IVF in murine oocytes. Anti-rFA-1 antibod-
ies specifically reacted with a protein band (of
approximately 47 kDa) only in the testis extract, in theReproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/11
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Western blotting procedure. These findings make the FA-
1 antigen one of promising candidates for immunocon-
traception studies. A human homologue of the murine
FA-1 cDNA has been also obtained and characterized,
proving its novelty and expression limited exclusively to
human testis on the mRNA as well as on the protein level
[26]. The antibody to the recombinant human FA-1 anti-
gen caused a significant (P < 0.01) and concentration –
dependent inhibition of human sperm capacitation and
acrosome reaction by blocking tyrosine phosphorylation
of the FA-1 antigen. The FA-1 antigen has been already
applied in a clinical trial for adsorption of IgA and IgG
autoantibodies from the surface of sperm cells of immu-
noinfertile men thus improving their fertilizing potential
[27].
One of the antigens identified by a serum sample from an
infertile ASA-positive women, is the BS-17 antigen [28].
Immunofluorescent studies with human, rat, rabbit,
mouse and hamster spermatozoa showed localization of
this antigen on the surface of the acrosomal region of
mammalian spermatozoa with variable (species-depend-
ent) localization in the sperm tail. The human testis λgt11
cDNA expression library was probed with polyclonal anti-
BS-17 antibodies. The positive clone yielded a cDNA frag-
ment, consisting of 758 base pairs with an open reading
frame of 558 bp, encoding a polypeptide composed of
186 aa residues, with high homology to calpastatin [29].
In situ hybridization, with human testis, showed that cal-
pastatine mRNA transcription had occurred only in sper-
matids [30]. The inhibition of calpastatin leads to a
premature acrosome reaction [31]. Polyclonal antibodies
to the BS-17 antigen inhibited human sperm from pene-
trating and fertilizing zona-free hamster oocytes [28]. The
suggested mechanism of this inhibition involved destabi-
lization of the calpastatin-calpain complex by the anti-B-
17 antibodies, thus calpain (calcium – dependent cysteine
endopeptidase) could trigger the sperm acrosome reac-
tion before it would reach the ovum, resulting in deterio-
ration of the sperm fertilizing capability.
In another study, the human testis λgt11 cDNA expression
library was screened with polyclonal antibodies to the EP-
20 glycoprotein [32]. A positive clone yielded a cDNA
(designated as HED-2), encoding a polypepide consisting
of 493 aa and having 99% of aa sequence identity with
zyxin, a constituent of the adhesive matrix of cell-cell and
cell-basement membrane junctions, involved in the inter-
cellular exchange and transport of nutrients and metabo-
lites, and binding of ligands to the plasma membrane
[33,34]. HED-2 protein, present in Sertoli cells, might par-
ticipate in the modulation of the differentiation of sper-
matogonia to spermatozoa.
Naz and Zhu [35] screened the mouse λgt11 library with
polyclonal sera obtained after immunization of mice with
human sperm antigens contained in bands belonging to
the Mw of 14–18 kDa, excised from the polyacrylamide
gel after SDS-PAGE. These antibodies recognized a cDNA
clone coding for an antigen designated as NZ-1. Neither
cDNA nor the amino acid (aa) sequence of its protein
product matched any known cDNA/aa sequence. North-
ern hybridization with mRNA isolated from 11 mice tis-
sues (liver, brain, lungs, kidney etc.) revealed the
expression of this sequence only in the testis. Then, it was
postulated that the NZ-1 antigen was a novel, sperm-spe-
cific antigen. Immunization of mice with the recombinant
NZ-1 antigen resulted in reducing their fertility rates.
NZ-2 antigen was identified during screening of human
testis cDNA library with antibodies contained in sera of
rabbits immunized with human sperm antigens con-
tained in the acrylamide gel bands (corresponding to 14–
18 kDa), excised from the slab gels after SDS-PAGE. In
immunoblotting with human sperm extract these sera rec-
ognized an antigen of approximately 20 kDa. Computer
assisted analysis of the positive cDNA clone sequence
revealed that this novel antigen (NZ-2) was coded in the
human chromosome 7 [53].
The cloning and characterization of a novel, testis-specific,
X-linked gene product, expressed exclusively in haploid
spermatids has been also reported [37]. In this study
cDNA clones were isolated from a human testis λZAP
cDNA library and probed with mouse monoclonal
antisperm antibodies. This yielded a clone designated
SPAN-Xa that allowed preparation of a DIG-labeled
SPAN-Xa cDNA probe. The latter was used to screen a
human testis λDR2 cDNA library and resulted in obtain-
ing a second clone, designated SPAN-Xb. The SPAN-Xa
and SPAN-Xb cDNA sequences were 92.2% identical and
their protein derivatives had 83.5% homology. SPAN-X
antigen is localized to nuclear craters and/or cytoplasmic
droplets of formaldehyde-fixed, methanol-permeabilized
human spermatozoa [37].
The FliTrx phage display library was screened with solubi-
lized human zona pellucida (ZP) in order to identify pep-
tide sequences that might be involved in ZP binding [37].
Twelve cones with strong binding responded. The clones
contained three aa sequences, designated as SNR12,
GHR12 and YLP12, reacted with 50% frequency. Compu-
ter software allowed designing a consensus sequence
(Consensus17), derived from all the clones. All four
sequences did not have any known nt/aa homologues in
the sequence databases. Peptides corresponding to YLP12
and Consensus17 sequences inhibited sperm binding
with the human ZP in the hemizona assay. The inhibition
was dose-dependent (stronger inhibition in higher con-Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/11
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centrations) and occurred only when the hemizonae were
incubated with the peptides prior to sperm. The YLP12
was a stronger inhibitor, so further studies focused on this
particular sequence. Fabs against it were produced and
applied for immunoprecipitation with solubilized 10 dif-
ferent human tissues. As a result, YLP12 Fabs specifically
recognized a protein band of about 72 kDa only in the tes-
tis. The antigen was immunolocalized in the acrosomal
region of the methanol-fixed human sperm [37]. It was
also indicated that YLP12 Fabs significantly reduced the
acrosome reaction [38]. Sera and SP samples of the
immune infertile men were ELISA tested for the reactivity
with the synthetic YLP12. Out of 15 immunoinfertile sera
samples, 46% were positive for IgM, 73% were positive for
IgG and 40% for IgA. Among 30 immunoinfertile SP sam-
ples 10% were positive for IgM, 20% were positive for IgG
and 43% for IgA. Serum and SP samples of the fertile indi-
viduals did not reveal positive reactions with the YLP12
peptide [39]. In this study, antipeptide antibodies eluted
from sera and SP samples of infertile individuals reacted
with a specific band of about 72 kDa in the human testis,
in immunoblotting.
YLP12 was further studied for its immunocontraceptive
potential in the mouse model [40]. A vaccine was
obtained by conjugating the synthetic YLP12 peptide with
the binding domain of recombinant cholera toxin and its
effect on fertility rates and tissue specificity was examined.
In this study, intramuscularly and intranasal immuniza-
tion of the female mice caused 70,3 and 61,4% overall
reduction in fertility, respectively. Fertility of the sensi-
tized animals could be regained either voluntarily (by
intravaginal administration of the YLP12 peptide) or
involuntary (by natural declining of the antibody concen-
tration in sera). Immunoblotting analysis revealed that
antibodies resulting from vaccination were tissue-specific
and recognized a specific protein band of about 72 kDa in
the testis extract and a band of approximately 50 kDa in
the sperm extract, the entities were not observed in the
extracts of 10 murine somatic tissues. The authors sug-
gested that the YLP12 peptide sequence was a part of a 72
kDa protein, that is synthesized during spermatogenesis
in the testis and then is modified or cleaved during epidi-
dymal transit. The 50 kDa antigen is localized on the sur-
face of the acrosome and tail of mature sperm cells. In
conclusion, the properties of the YLP12 peptide (i.e. its
capability to induce sperm-specific response, long-lasting
and reversible contraceptive effect, with a complete regain
of fertility) make it an attractive candidate for immuno-
contraception.
Human testis cDNA – ZAP II library screening allowed
also to discover another novel and testis-specific antigen,
named a contraceptive vaccinogen (CV) [41]. The recom-
binant form of this antigen was obtained and specific anti-
bodies produced. In vitro studies showed inhibition of
human sperm from penetration of zona-free hamster
oocytes and human sperm binding to human zona pellu-
cida. The CV antigen is also expressed in murine sperm
[42] suggesting a feasibility of animal model for studying
its immunocontraceptive potential.
Two-dimensional electrophoresis
In yet another approach, high resolution two-dimen-
sional electrophoresis with separation of sperm antigens
in the first dimension by either IEF or NEPHGE followed
by SDS-PAGE and Western blotting can be applied to
study sperm – immune system interactions. Two-dimen-
sional electrophoresis, according to some authors is cur-
rently the most powerful and informative tool available
for analysis of complex mixtures of polypeptides [43].
In the study of Naaby-Hansen et al. [44] a repertoire of
1397 silver-stained proteins has been obtained, digitized,
catalogued and characterized by the Mw, pI and the shape
of spots. Some of them were identified as sperm coating
antigens, derived from SP.
These data were afterwards employed for the identifica-
tion of human sperm antigens reacting with the sera of
infertile women having sperm immobilizing antibodies
[43]. Percoll-purified human sperm proteins were sepa-
rated by IEF followed by SDS-PAGE and transferred to
nitrocellulose. Then, the membranes were immunoblot-
ted with either SI-positive or SI-negative serum samples.
Then, Mw and pI identified the subset of prominent
immunoreactive sperm surface antigens: (32.6, 5.9),
(35.6, 6.6), (58.6, 4.9), (93.8, 5.5).
The study performed by Shetty et al. [45] also employed
2-D gel electrophoresis, with the separation of human
sperm proteins in the first dimension by IEF or NEPHGE,
followed by PAGE. Sera of infertile male and female
patients were chosen for further study on the basis of their
high IBT reactivity (over 60%). In this study 6 auto- and
isoantigens were appointed as possibly being relevant to
infertility (kDa, pI): (34.0, 4.2), (38.0, 4.3), (60.0, 6.2),
(60.0, 6.4), (88.2, 4.0), (140.0, 4.2). These antigens dif-
fered from the ones identified by the SI-positive sera used
by Shibahara et al. [43], probably because ASA detected by
means of IBT may not be associated with infertility and
could differ from SI-ASA. Shibahara and colleagues [43]
suggested that sperm surface antigens, corresponding to SI
antigens may be considered as the ideal targets in develop-
ing immunocontraceptives. However, the detected spots
representing candidate sperm surface antigens must be
sequenced, their cognate cDNA cloned and tissue specifi-
city established before immunocontraceptive trials.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/11
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A novel human sperm membrane antigen, SAMP32
(sperm acrosomal membrane-associated protein 32) was
discovered from two-dimensional analysis of human
sperm extracts containing hydrophobic proteins that were
partitioned into Triton X-114 [46]. Among several dozen
hydrophobic sperm proteins microsequenced by mass
spectrometry, 4 spots shared the same peptide sequences.
Cloning the corresponding cDNA it was revealed that they
were products of a single gene, localized to the chromo-
some 6 in human. Further investigations revealed that
SAMP32 expression was testis-specific, with the expres-
sion to Golgi phase round spermatids and subsequent
stages of acrosome biogenesis, and in mature spermato-
zoa it was localized on the inner acrosomal membrane in
the principal and the equatorial segments of the sperm
acrosome. Before acrosome formation, SAMP32 expres-
sion did not occur. SAMP32 is an isoantigen in humans.
Rat antibodies to the recombinant SAMP32 protein signif-
icantly suppressed the binding and the fusion of capaci-
tated human spermatozoa with zona-free hamster eggs in
comparison to preimmune serum. Serum from an ASA-
positive infertile man strongly reacted with the recom-
binant SAMP32 antigen, suggesting that it might be one of
the antigens related to immune infertility and (on the
basis of in vitro studies) that it might have a role either in
binding and fusion of sperm with the oolemma or in
sperm internalization [47].
Recently, a novel epididymis – specific glycoprotein, E-3
was identified in Lewis rats by means of 2-D gel electro-
phoresis, followed by immunoblotting with rat hyperim-
mune sera raised against isologous rat sperm [47]. The E-
3 antigen (28 kDa, pI 3.5) is present in the epididymis but
not in testis and other tissues (as revealed by Northern
blotting). Indirect immunofluorescence showed its pres-
ence on the sperm tail with less intense staining on the
sperm head. The E-3 protein sequence did not match any
known proteins from the databank but resembled other
newly discovered proteins, e.g. ESP13.2 from human and
macaque as well as 2 putative novel human proteins,
detected by sequencing of the human genome [47]. Its
defensine-like motif suggests its role in protecting sperm
and the epididymis from microbial infections.
Bohring et al. [48] performed 2-D electrophoresis of
highly enriched sperm membrane proteins and immuno-
blotted them with 20 MAR-positive SP samples of infertile
individuals. Overall, 18 immunoreactive antigens were
obtained, out of which 6 were analyzed using matrix-
assisted laser desorption ionization- mass spectrometry
(MALDI-MS) and peptide matching. Among the studied
SP samples, 95% reacted with the disulphide isomerase
ER60, 90% recognized the inactive form of caspase-3 and
75% of the SP samples reacted with the spots identified as
heat shock proteins (HSP70 and HSP70.2). The other
entities recognized by ASA of infertile men reacted with
two subunits of the proteasome (C2 and zeta chain).
According to the authors, however, additional experi-
ments with using specific antibodies would be necessary
to demonstrate that the protein spots characterized are
indeed related to the proteins identified by MALDI-MS.
Their role in sperm function must be also determined.
Two-dimensional electrophoresis analysis was also useful
for identification of targets at the intersection between the
calcium and protein tyrosine kinase signal transduction
pathways during capacitation of human spermatozoa
[49]. This strategy resulted in the identification of
another, unique to spermatogenic lineage, 86 kDa anti-
gen, a calcium-binding tyrosine phosphorylation-regu-
lated protein (CABYR) [49]. Its gene is localized to the
human chromosome 18 and consists of 5 exons. In meth-
anol – fixed human sperm it was localized by indirect
immunofluorescence on the principal piece of the sperm
tail. Electron microscopy analysis revealed its distribution
over the fibrous sheath compartment, including the sur-
face of the longitudinal columns and ribs. Calcium bind-
ing capacity of CABYR may represent one molecular
mechanism for capacitation and hyperactivation [49].
Conclusions
Many studies have been performed so far on candidate
antigens from male and female gametes in order to dem-
onstrate their ability to induce auto and/or isoimmune
response interfering with fertility [50]. Clearly, several
antigens of gametogenic origin have been successfully
applied to induce infertility in experimental animals.
Because no single predominant target of polyclonal
antisperm antibodies has been identified, but instead a
number of sperm proteins have been obtained, an effec-
tive immunocontraceptive vaccine would be probably
consisting of several specific antigenic epitopes (eliciting
sperm-specific antibody response but lacking any side
effects) included in a single formula. Perhaps, monospe-
cific antibodies to sperm antigens may be combined for
immunocontraceptive purposes in the form of intravagi-
nal sperm-specific spermicides. A first recombinant mini-
antibody has been already engineered to the tissue-
specific carbohydrate epitope located on the sperm glyco-
form of the CD52 [51] antigen and shown to agglutinate
human sperm cells in a tangled pattern [52].
The identification of sperm antigens relevant to fertiliza-
tion opens up opportunities also for diagnosis and treat-
ment of immune infertility. At present, antisperm
antibodies are suppressed systemically and direct target-
ing ASA is not possible. It may be speculated whether
using monoclonal antibodies for treatment of immune
infertility would be possible in the future.Reproductive Biology and Endocrinology 2004, 2 http://www.rbej.com/content/2/1/11
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List of abbreviations
ASA – antisperm antibodies
ECL – enhanced chemiluminescence
Mw – molecular weight
DIG – digoxigenin
ZP – zona pellucida
SP – seminal plasma
IEF – isoelectric focusing
NEPHGE – non-equilibrium pH gradient electrophoresis
2-D – two dimensional
SI – sperm immunobilizing
IBT – immunobead binding test
MAR – mixed antiglobulin reaction
MALDI-MS – matrix assissted laser desorption ionisation
mass spectrometry
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